冷沉淀的临床应用  

Clinical application of cryoprecipitate

作　　者：郭博[1] 陈丽[1] 管政[1] 

机构地区：[1]蚌埠医学院第一附属医院输血科,安徽蚌埠233004

出　　处：《蚌埠医学院学报》2011年第7期765-766,769,共3页Journal of Bengbu Medical College

摘　　要：目的:加强冷沉淀临床应用的输血管理,合理应用冷沉淀,降低经输血传播的疾病发生率,减少不良输血反应。方法:对蚌埠医学院第一附属医院2008～2010年冷沉淀的应用量(U)和2010年冷沉淀的应用病例进行统计分析,计算冷沉淀的合理应用率及不合理应用率。结果:2009、2010年的冷沉淀年均应用量是2008年的3.4倍,2010年冷沉淀的合理应用率为43.8%,不合理应用率为56.2%。结论:2009～2010年,冷沉淀的应用量过大,2010年不合理应用率过高,必须加强冷沉淀临床应用的输血管理,严格掌握冷沉淀的输注适应证及输注指征,杜绝不必要的输注。Objective：To strengthen the transfusion management of cryoprecipitate in clinical use and apply cryoprecipitate to reasonable patients in order to decrease occurrence of diseases which spread by transfusion and reduce abnormal transfusion reaction.Methods：The amounts of cryoprecipitate（units） that had been applied in the first affiliated hospital of Bengbu Medical College from 2008-2010 years and the cases in 2010 year were statistical analyzed.The reasonable use rate of cryoprecipitate and the unreasonable use rate were counted.Results：The annual average amounts of cryoprecipitate that had been applied in the years 2009 and 2010 were 3.4 times as many as in the year 2008.The reasonable use rate of cryoprecipitate was 43.8% and the unreasonable use rate was 56.2% in the year 2010.Conclusions：The amounts of cryoprecipitate that had been applied in the first affiliated hospital of Bengbu Medical College were excessive in the years 2009 and 2010.the unreasonable use rate of cryoprecipitate was high in the year 2010.So the transfusion management of cryoprecipitate should be strengthened in clinical uses,and the suitable cases should be strictly choosen and unnecessary transfusion of cryoprecipitate should be stopped.

关 键 词：输血 冷沉淀 红细胞 冷冻血浆 

分 类 号：R457.1[医药卫生—治疗学]